Target intelligence / Profile preview

Origin recognition complex subunit 1 (ORC1)

Target
ORC1
Molecular classification
DNA replication licensing factor, AAA+ ATPase family protein, Chromatin-associated protein
01

Overview

Origin recognition complex subunit 1 (ORC1) is the largest component of the hexameric origin recognition complex (ORC), which is essential for the initiation of DNA replication in all eukaryotes. ORC1, encoded by the ORC1 gene, contains a bromo-adjacent homology (BAH) domain and an AAA+ ATPase domain, allowing it to bind origins of replication on DNA and direct assembly of the pre-replication complex by recruiting additional factors such as CDC6, MCM2-7, and Cdt1. ORC1 levels and chromatin binding are tightly regulated across the cell cycle; its phosphorylation status and degradation help coordinate pre-replicative complex formation. In addition to DNA replication, ORC1 interacts with chromatin through histone modifications, contributes to heterochromatin association, and is needed for proper centrosome and centriole duplication. Loss-of-function mutations in ORC1 cause developmental syndromes such as Meier-Gorlin syndrome, emphasizing its essential role in human growth and genome stability. No direct drugs are clinically used to target ORC1, and because it is indispensable for cell proliferation, it is not considered a viable therapeutic target except in rare research contexts.

Other names
ORC1LPARC1HSORC1Replication control protein 1Origin recognition complex, subunit 1 homolog, S. cerevisiae, homolog-like
02

Biological functions

Initiation of DNA replicationPre-replication complex assemblyRegulation of centrosome and centriole duplicationChromatin structure maintenance and epigenetic regulationHeterochromatin bindingRegulation of cell cycle progression
03

Disease associations

Microcephalic primordial dwarfism (Meier-Gorlin syndrome)Potential roles in cancer (disruption affects proliferation and genome stability)Genomic instability syndromes
04

Safety considerations

Essential for cell division; complete inhibition or loss-of-function leads to cell cycle arrest, lack of cell proliferation, and developmental disorders (such as Meier-Gorlin syndrome)Therapeutic targeting may be challenging due to fundamental roles in all proliferating cells
05

Biomarkers

Mutations in ORC1 are diagnostic for certain forms of Meier-Gorlin syndrome and related primordial dwarfism syndromes

Beyond the preview

Go deeper on Origin recognition complex subunit 1 (ORC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Origin recognition complex subunit 1 (ORC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call